Anstee QM, Lucas KJ, Francque S, Abdelmalek MF, et al. Tropifexor plus cenicriviroc combination versus monotherapy in non-alcoholic steatohepatitis: Results from the Phase 2b TANDEM study. Hepatology 2023 May 11. doi: 10.1097/HEP.0000000000000439.
PMID: 37162151